Unexplained deterioration during antituberculous therapy in children and adolescents: Clinical presentation and risk factors

Pediatric Infectious Disease Journal

Volumn 31, Issue 2, 2012, Pages 129-133

  Thampi, Nisha ^a   Stephens, Derek ^b   Rea, Elizabeth ^b,c   Kitai, Ian ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO PUBLIC HEALTH   (Canada)

Author keywords

Corticosteroids; Malnutrition; Paradoxical; Pediatric; Tuberculosis

Indexed keywords

ISONIAZID; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN;

ABDOMINAL MASS; ADOLESCENT; ARTICLE; CHILD; CORTICOSTEROID THERAPY; DISEASE DURATION; FEMALE; GENERAL CONDITION DETERIORATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFANT; LUNG TUBERCULOSIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; MALE; RISK FACTORS; TREATMENT FAILURE; TUBERCULOSIS;

EID: 84858154738     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318239134c     Document Type: Article

References (32)

1. Cheng VC, Ho PL, Lee RA, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002;21:803-809. (Pubitemid 35435702)
2. Breen RA, Smith CJ, Bettinson H, et al. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax. 2004;59:704 -707.
3. Hawkey CR, Yap T, Pereira J, et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis. 2005;40:1368-1371. (Pubitemid 40570251)
4. Chien JW, Johnson JL. Paradoxical reactions in HIV and pulmonary TB. Chest. 1998;114:933-936. (Pubitemid 28433762)
5. Narita M, Ashkin D, Hollender ES, et al. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998;158:157-161. (Pubitemid 28337174)
6. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005;5:361-373. (Pubitemid 40779257)
7. Fishman JE, Saraf-Lavi E, Narita M, et al. Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy. Am J Roentgenol. 2000;174:43- 49.
8. Choremis CB, Padiatellis C, Zoumboulakis D, et al. Transitory exacerbation of fever and roentgenographic findings during treatment of tuberculosis in children. Am Rev Tuberc. 1955;72:527-536.
9. Kumar R, Prakash M, Jha S. Paradoxical response to chemotherapy in neurotuberculosis. Pediatr Neurosurg. 2006;42:214-222. (Pubitemid 43787317)
10. Park JA, Park SS, Park SE. A paradoxical reaction during antituberculosis therapy for congenital tuberculosis. Int J Infect Dis. 2009;13:e279-e281.
11. Kitai I, Malloy P. A clinical approach to paediatric tuberculosis in Canada. Paediatr Child Health. 2003;8:162-170. (Pubitemid 36628699)
12. Kitai I, Malloy P, Long R. Pediatric tuberculosis. In: Long R, Ellis E, eds. The Canadian Tuberculosis Standards. 6th ed. Ottawa. Ontario, Canada: Health Canada and the Canadian Lung Association; 2007:308-319.
13. Tuberculosis Coalition for Technical Assistance. International standards for tuberculosis care (ISTC). The Hague, The Netherlands: Tuberculosis Coalition for Technical Assistance; 2006.
14. Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8:516-523. (Pubitemid 352005824)
15. Loeffler AM. Pediatric tuberculosis. Semin Respir Infect. 2003;18:272-291. (Pubitemid 38018771)
16. Cheng VC, Yam WC, Woo PC, et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis. 2003;22:597-602. (Pubitemid 37363538)
17. Phongsamart W, Kitai I, Gardam M, et al. A population-based study of tuberculosis in children and adolescents in Ontario. Pediatr Infect Dis J. 2009;28:416-419.
18. Kam A, Ford-Jones L, Malloy P, et al. Active tuberculosis among adolescents in toronto, Canada: clinical features and delays in diagnosis. Pediatr Infect Dis J. 2007;26:355-356. (Pubitemid 46596664)
19. Cheng SL, Wang HC, Yang PC. Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2007;11:1290-1295.
20. Onal IK, Bayraktar Y, Unal S. Paradoxical deterioration during the course of antituberculous treatment. J Natl Med Assoc. 2006;98:954-955. (Pubitemid 43846256)
21. Meintjes G, Rabie H, Wilkinson RJ, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy. Clin Chest Med. 2009;30:797-810, x.
22. Murdoch DM, Venter WD, Feldman C, et al. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS. 2008;22:601-610. (Pubitemid 351640593)
23. Campbell IA, Dyson AJ. Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle. 1977;58:171-179. (Pubitemid 8247013)
24. Pepper DJ, Marais S, Maartens G, et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis. 2009;48:e96-e107.
25. Jain SK, Kwon P, Moss WJ. Management and outcomes of intracranial tuberculomas developing during antituberculous therapy: case report and review. Clin Pediatr (Phila). 2005;44:443- 450.
26. Bukharie H. Paradoxical response to anti-tuberculous drugs: resolution with corticosteroid therapy. Scand J Infect Dis. 2000;32:96 -97.
27. Garcia Vidal C, Rodriguez Fernandez S, Martinez Lacasa J, et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis. 2005;40:756-759.
28. Blackmore TK, Manning L, Taylor WJ, et al. Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis. 2008;47:e83-e85.
29. Wang ME, Castillo ME, Montano SM, et al. Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru. Pediatr Infect Dis J. 2009;28:900-903.
30. Markman M, Eagleton LE. Paradoxical clinical improvement and radiographic deterioration in anergic patients treated for far advanced tuberculosis. N Engl J Med. 1981;305:167. (Pubitemid 11073085)
31. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the prechemotherapy era. Int J Tuberc Lung Dis. 2004;8:392-402. (Pubitemid 38624845)
32. Nelson LJ, Schneider E, Wells CD, et al. Epidemiology of childhood tuberculosis in the United States, 1993-2001: the need for continued vigilance. Pediatrics. 2004;114:333-341. (Pubitemid 39006658)